BAG3 and glioblastoma: GX15-070 is unique in that it suppressed Bag3 and Usp9X levels simultaneously in glioblastoma cells independently of their TP53 status, which most likely further enhanced GX15-070 mediated susceptibility to BH3-mimetics.